Persisting SARS-CoV-2 viraemia after rituximab therapy: two cases with fatal outcome and a review of the literature.
Br J Haematol
; 190(2): 185-188, 2020 07.
Article
in English
| MEDLINE | ID: covidwho-626838
ABSTRACT
SARS-CoV-2 infection can cause severe pneumonia (COVID-19). There is evidence that patients with comorbidities are at higher risk of a severe disease course. The role of immunosuppression in the disease course is not clear. In the present report, we first describe two cases of persisting SARS-CoV-2 viraemia with fatal outcome in patients after rituximab therapy.
Keywords
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Pneumonia, Viral
/
Viremia
/
Coronavirus Infections
/
Rituximab
Type of study:
Case report
/
Diagnostic study
/
Prognostic study
Topics:
Long Covid
Limits:
Aged
/
Humans
/
Male
/
Middle aged
Language:
English
Journal:
Br J Haematol
Year:
2020
Document Type:
Article
Affiliation country:
Bjh.16896
Similar
MEDLINE
...
LILACS
LIS